Golden Ally Lifetech Group, Inc.
Golden Ally Lifetech Group, Inc.
Your view on AQPW
Overview
What the company does, where it operates, and who runs it.
About Golden Ally Lifetech Group, Inc.
- Industry
- Beverages - Non-Alcoholic
- Sector
- Consumer Defensive
- CEO
- Oliver Keren Ban
- Headquarters
- 901 S. Mopack Exp Building 1, Austin, TX, US
- Industry
- Beverages - Non-Alcoholic
- Sector
- Consumer Defensive
- CEO
- Oliver Keren Ban
- Headquarters
- 901 S. Mopack Exp Building 1, Austin, TX, US
Golden Ally Lifetech Group, Inc., a development stage company, focuses on developing advanced technologies, energy solutions, and medical devices. It focuses on development of bioscience and sport medicines, including Sterilal self-sanitizing devices, PASS smart denture mouth guards, handheld heart attack sensors, and melanoma detection systems.
The company also offers InCharge magnetic-based battery device that provides energy; and develops applications for de-icing application of graphene for use in the airline industry. The company was formerly known as Signet International Holdings, Inc. and changed its name to Golden Ally Lifetech Group, Inc. in July 2022.
Golden Ally Lifetech Group, Inc. was incorporated in 2003 and is based in Austin, Texas.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Golden Ally Lifetech Group, Inc., and the rating behind it. AQPW last traded at $0.0001; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Golden Ally Lifetech Group, Inc.. Starting points for Golden Ally Lifetech Group, Inc.: EPS -$0.07, beta 1.15 — an Beverages - Non-Alcoholic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Golden Ally Lifetech Group, Inc.. Golden Ally Lifetech Group, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Golden Ally Lifetech Group, Inc.. Trailing twelve-month EPS for Golden Ally Lifetech Group, Inc. stands at -$0.07. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Golden Ally Lifetech Group, Inc.. Golden Ally Lifetech Group, Inc. has reported as a listed company since 2007. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Golden Ally Lifetech Group, Inc. valued side by side against its closest peers. Golden Ally Lifetech Group, Inc. is measured against Beverages - Non-Alcoholic peers within the Consumer Defensive sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Golden Ally Lifetech Group, Inc., and how their positions are changing. At a $740,856 market value, institutional positions materially move Golden Ally Lifetech Group, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Golden Ally Lifetech Group, Inc. executives and directors. Shares of Golden Ally Lifetech Group, Inc. have traded between $0.0001 and $0.27 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Golden Ally Lifetech Group, Inc.. Golden Ally Lifetech Group, Inc. is a $740,856 Consumer Defensive company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Golden Ally Lifetech Group, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Golden Ally Lifetech Group, Inc.. Coverage tracks Golden Ally Lifetech Group, Inc. within Beverages - Non-Alcoholic (Consumer Defensive). Press releases and market coverage, newest first.